Everlywell, Inc
Austin, Texas, 78703, United States
NCT Number: NCT05042232
The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Austin, Texas, 78703, United States
This virtual observational cohort study will describe patient behaviors and clinical outcomes of subjects who tested positive for COVID-19. Among those with positive tests, predictors of time to recovery, post-COVID function and outcomes will be identified. Individuals who test negative and positive for SARS-CoV-2 will be enrolled in the study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants who have tested positive for SARS-CoV-2, both with and without symptoms
Participants who have tested negative for SARS-CoV-2
Time frame: Up to 12 months
Time frame: Up to 12 months
Time frame: Up to 12 months
Time frame: Up to 12 months
Time frame: Up to 12 months
Everly Health
Industry
Assessing Behavioral, Functional, and Clinical Patient-Reported Outcomes (PROs) in Subjects Diagnosed With COVID-19
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05142553
COVID-19, Coronaviridae Infections
Badalona, BARCELONA, Spain
View Trial DetailsNCT05077332
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection
Miami, Florida, United States
View Trial DetailsNCT05133596
Coronaviridae Infections, Coronavirus Infections
Paris, France
View Trial DetailsNCT05004181
COVID-19, Coronaviridae Infections
Long Beach, California, United States
View Trial Details